nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—Fluorouracil—colon cancer	0.144	0.596	CbGbCtD
Memantine—CYP2B6—Irinotecan—colon cancer	0.0974	0.404	CbGbCtD
Memantine—HTR3A—myenteric nerve plexus—colon cancer	0.0241	0.555	CbGeAlD
Memantine—SLC22A2—Abacavir transmembrane transport—ABCB1—colon cancer	0.00282	0.0632	CbGpPWpGaD
Memantine—SLC22A2—renal system—colon cancer	0.00258	0.0595	CbGeAlD
Memantine—GRIN2A—vagina—colon cancer	0.00243	0.056	CbGeAlD
Memantine—SLC22A2—digestive system—colon cancer	0.00212	0.0488	CbGeAlD
Memantine—HTR3A—digestive system—colon cancer	0.00182	0.0421	CbGeAlD
Memantine—SLC22A2—Abacavir transport and metabolism—ABCB1—colon cancer	0.00162	0.0363	CbGpPWpGaD
Memantine—CYP2A6—vagina—colon cancer	0.00158	0.0365	CbGeAlD
Memantine—CYP2A6—liver—colon cancer	0.00134	0.0308	CbGeAlD
Memantine—CYP2C19—digestive system—colon cancer	0.00115	0.0266	CbGeAlD
Memantine—CYP2B6—renal system—colon cancer	0.0011	0.0254	CbGeAlD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—BRAF—colon cancer	0.00103	0.0231	CbGpPWpGaD
Memantine—CYP2C19—vagina—colon cancer	0.00102	0.0235	CbGeAlD
Memantine—CYP2B6—Metapathway biotransformation—CHST4—colon cancer	0.001	0.0224	CbGpPWpGaD
Memantine—CYP2B6—lymphoid tissue—colon cancer	0.000914	0.0211	CbGeAlD
Memantine—CYP2B6—digestive system—colon cancer	0.000903	0.0208	CbGeAlD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—BRAF—colon cancer	0.000901	0.0202	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—BRAF—colon cancer	0.000878	0.0197	CbGpPWpGaD
Memantine—CYP2C19—liver—colon cancer	0.000859	0.0198	CbGeAlD
Memantine—GRIN2A—Post NMDA receptor activation events—BRAF—colon cancer	0.00085	0.019	CbGpPWpGaD
Memantine—CYP2B6—vagina—colon cancer	0.000797	0.0184	CbGeAlD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—colon cancer	0.000783	0.0175	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CHST4—colon cancer	0.000757	0.017	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—BRAF—colon cancer	0.000741	0.0166	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—BRAF—colon cancer	0.000723	0.0162	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—colon cancer	0.000683	0.0153	CbGpPWpGaD
Memantine—CYP2B6—liver—colon cancer	0.000672	0.0155	CbGeAlD
Memantine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—colon cancer	0.000666	0.0149	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—colon cancer	0.000666	0.0149	CbGpPWpGaD
Memantine—Shock—Irinotecan—colon cancer	0.000661	0.000986	CcSEcCtD
Memantine—Nervous system disorder—Irinotecan—colon cancer	0.000659	0.000983	CcSEcCtD
Memantine—Agranulocytosis—Capecitabine—colon cancer	0.000658	0.000981	CcSEcCtD
Memantine—Thrombocytopenia—Irinotecan—colon cancer	0.000658	0.000981	CcSEcCtD
Memantine—Anorexia—Vincristine—colon cancer	0.000658	0.000981	CcSEcCtD
Memantine—Irritability—Methotrexate—colon cancer	0.00065	0.000969	CcSEcCtD
Memantine—Hyperhidrosis—Irinotecan—colon cancer	0.00065	0.000969	CcSEcCtD
Memantine—Confusional state—Fluorouracil—colon cancer	0.000649	0.000968	CcSEcCtD
Memantine—Mood swings—Methotrexate—colon cancer	0.000646	0.000962	CcSEcCtD
Memantine—Hypotension—Vincristine—colon cancer	0.000645	0.000961	CcSEcCtD
Memantine—Bradycardia—Capecitabine—colon cancer	0.000645	0.000961	CcSEcCtD
Memantine—Oedema—Fluorouracil—colon cancer	0.000644	0.00096	CcSEcCtD
Memantine—Anorexia—Irinotecan—colon cancer	0.000641	0.000955	CcSEcCtD
Memantine—Ataxia—Methotrexate—colon cancer	0.000641	0.000955	CcSEcCtD
Memantine—Infection—Fluorouracil—colon cancer	0.00064	0.000953	CcSEcCtD
Memantine—Haemoglobin—Capecitabine—colon cancer	0.000637	0.000949	CcSEcCtD
Memantine—Rhinitis—Capecitabine—colon cancer	0.000635	0.000946	CcSEcCtD
Memantine—Haemorrhage—Capecitabine—colon cancer	0.000633	0.000944	CcSEcCtD
Memantine—Hepatitis—Capecitabine—colon cancer	0.000633	0.000944	CcSEcCtD
Memantine—Nervous system disorder—Fluorouracil—colon cancer	0.000631	0.000941	CcSEcCtD
Memantine—Thrombocytopenia—Fluorouracil—colon cancer	0.00063	0.00094	CcSEcCtD
Memantine—Hypoaesthesia—Capecitabine—colon cancer	0.00063	0.000939	CcSEcCtD
Memantine—Liver function test abnormal—Methotrexate—colon cancer	0.000629	0.000938	CcSEcCtD
Memantine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000629	0.000937	CcSEcCtD
Memantine—Pharyngitis—Capecitabine—colon cancer	0.000629	0.000937	CcSEcCtD
Memantine—Tachycardia—Fluorouracil—colon cancer	0.000628	0.000937	CcSEcCtD
Memantine—Hypotension—Irinotecan—colon cancer	0.000628	0.000936	CcSEcCtD
Memantine—Urinary tract disorder—Capecitabine—colon cancer	0.000625	0.000932	CcSEcCtD
Memantine—Insomnia—Vincristine—colon cancer	0.000624	0.000931	CcSEcCtD
Memantine—Oedema peripheral—Capecitabine—colon cancer	0.000624	0.00093	CcSEcCtD
Memantine—Connective tissue disorder—Capecitabine—colon cancer	0.000622	0.000928	CcSEcCtD
Memantine—Urethral disorder—Capecitabine—colon cancer	0.000621	0.000925	CcSEcCtD
Memantine—Paraesthesia—Vincristine—colon cancer	0.00062	0.000924	CcSEcCtD
Memantine—Anorexia—Fluorouracil—colon cancer	0.000614	0.000915	CcSEcCtD
Memantine—Visual impairment—Capecitabine—colon cancer	0.00061	0.00091	CcSEcCtD
Memantine—Insomnia—Irinotecan—colon cancer	0.000608	0.000906	CcSEcCtD
Memantine—Paraesthesia—Irinotecan—colon cancer	0.000604	0.0009	CcSEcCtD
Memantine—Hypotension—Fluorouracil—colon cancer	0.000602	0.000897	CcSEcCtD
Memantine—Decreased appetite—Vincristine—colon cancer	0.0006	0.000894	CcSEcCtD
Memantine—Dyspnoea—Irinotecan—colon cancer	0.000599	0.000893	CcSEcCtD
Memantine—Erythema multiforme—Capecitabine—colon cancer	0.000599	0.000892	CcSEcCtD
Memantine—Somnolence—Irinotecan—colon cancer	0.000598	0.000891	CcSEcCtD
Memantine—Gastrointestinal disorder—Vincristine—colon cancer	0.000596	0.000888	CcSEcCtD
Memantine—Fatigue—Vincristine—colon cancer	0.000595	0.000887	CcSEcCtD
Memantine—Eye disorder—Capecitabine—colon cancer	0.000592	0.000882	CcSEcCtD
Memantine—Dyspepsia—Irinotecan—colon cancer	0.000592	0.000882	CcSEcCtD
Memantine—Tinnitus—Capecitabine—colon cancer	0.00059	0.00088	CcSEcCtD
Memantine—Constipation—Vincristine—colon cancer	0.00059	0.00088	CcSEcCtD
Memantine—Pain—Vincristine—colon cancer	0.00059	0.00088	CcSEcCtD
Memantine—Asthma—Methotrexate—colon cancer	0.000589	0.000878	CcSEcCtD
Memantine—Flushing—Capecitabine—colon cancer	0.000588	0.000876	CcSEcCtD
Memantine—Cardiac disorder—Capecitabine—colon cancer	0.000588	0.000876	CcSEcCtD
Memantine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000587	0.000874	CcSEcCtD
Memantine—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000586	0.0131	CbGpPWpGaD
Memantine—Decreased appetite—Irinotecan—colon cancer	0.000584	0.000871	CcSEcCtD
Memantine—Insomnia—Fluorouracil—colon cancer	0.000582	0.000868	CcSEcCtD
Memantine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—colon cancer	0.000581	0.013	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00058	0.000865	CcSEcCtD
Memantine—Fatigue—Irinotecan—colon cancer	0.00058	0.000864	CcSEcCtD
Memantine—Paraesthesia—Fluorouracil—colon cancer	0.000578	0.000862	CcSEcCtD
Memantine—Pancreatitis—Methotrexate—colon cancer	0.000578	0.000861	CcSEcCtD
Memantine—Pain—Irinotecan—colon cancer	0.000575	0.000857	CcSEcCtD
Memantine—Constipation—Irinotecan—colon cancer	0.000575	0.000857	CcSEcCtD
Memantine—Angiopathy—Capecitabine—colon cancer	0.000575	0.000856	CcSEcCtD
Memantine—Dyspnoea—Fluorouracil—colon cancer	0.000574	0.000856	CcSEcCtD
Memantine—Somnolence—Fluorouracil—colon cancer	0.000572	0.000853	CcSEcCtD
Memantine—Immune system disorder—Capecitabine—colon cancer	0.000572	0.000853	CcSEcCtD
Memantine—Mediastinal disorder—Capecitabine—colon cancer	0.000571	0.000851	CcSEcCtD
Memantine—Chills—Capecitabine—colon cancer	0.000568	0.000847	CcSEcCtD
Memantine—Dyspepsia—Fluorouracil—colon cancer	0.000567	0.000845	CcSEcCtD
Memantine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—colon cancer	0.000566	0.0127	CbGpPWpGaD
Memantine—Arrhythmia—Capecitabine—colon cancer	0.000566	0.000843	CcSEcCtD
Memantine—Gastrointestinal pain—Vincristine—colon cancer	0.000564	0.000841	CcSEcCtD
Memantine—CYP2A6—Fluoropyrimidine Activity—TYMS—colon cancer	0.000562	0.0126	CbGpPWpGaD
Memantine—Decreased appetite—Fluorouracil—colon cancer	0.00056	0.000834	CcSEcCtD
Memantine—Alopecia—Capecitabine—colon cancer	0.00056	0.000834	CcSEcCtD
Memantine—Pancytopenia—Methotrexate—colon cancer	0.000559	0.000834	CcSEcCtD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—colon cancer	0.000559	0.0125	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000556	0.000828	CcSEcCtD
Memantine—Mental disorder—Capecitabine—colon cancer	0.000555	0.000827	CcSEcCtD
Memantine—Feeling abnormal—Irinotecan—colon cancer	0.000554	0.000826	CcSEcCtD
Memantine—Malnutrition—Capecitabine—colon cancer	0.000551	0.000822	CcSEcCtD
Memantine—Neutropenia—Methotrexate—colon cancer	0.000551	0.000821	CcSEcCtD
Memantine—Dysuria—Methotrexate—colon cancer	0.000551	0.000821	CcSEcCtD
Memantine—Pain—Fluorouracil—colon cancer	0.000551	0.000821	CcSEcCtD
Memantine—Gastrointestinal pain—Irinotecan—colon cancer	0.00055	0.000819	CcSEcCtD
Memantine—Upper respiratory tract infection—Methotrexate—colon cancer	0.000547	0.000816	CcSEcCtD
Memantine—Abdominal pain—Vincristine—colon cancer	0.000546	0.000813	CcSEcCtD
Memantine—Body temperature increased—Vincristine—colon cancer	0.000546	0.000813	CcSEcCtD
Memantine—Flatulence—Capecitabine—colon cancer	0.000543	0.00081	CcSEcCtD
Memantine—Erectile dysfunction—Methotrexate—colon cancer	0.000542	0.000809	CcSEcCtD
Memantine—Dysgeusia—Capecitabine—colon cancer	0.00054	0.000805	CcSEcCtD
Memantine—Back pain—Capecitabine—colon cancer	0.000533	0.000795	CcSEcCtD
Memantine—Body temperature increased—Irinotecan—colon cancer	0.000531	0.000792	CcSEcCtD
Memantine—Abdominal pain—Irinotecan—colon cancer	0.000531	0.000792	CcSEcCtD
Memantine—Feeling abnormal—Fluorouracil—colon cancer	0.000531	0.000791	CcSEcCtD
Memantine—Pneumonia—Methotrexate—colon cancer	0.000528	0.000787	CcSEcCtD
Memantine—GRIN2A—Reelin signaling pathway—PIK3CA—colon cancer	0.000528	0.0118	CbGpPWpGaD
Memantine—Infestation—Methotrexate—colon cancer	0.000525	0.000783	CcSEcCtD
Memantine—Infestation NOS—Methotrexate—colon cancer	0.000525	0.000783	CcSEcCtD
Memantine—Depression—Methotrexate—colon cancer	0.000524	0.00078	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000521	0.000776	CcSEcCtD
Memantine—Vision blurred—Capecitabine—colon cancer	0.00052	0.000774	CcSEcCtD
Memantine—Tremor—Capecitabine—colon cancer	0.000517	0.00077	CcSEcCtD
Memantine—Renal failure—Methotrexate—colon cancer	0.000516	0.000769	CcSEcCtD
Memantine—Ill-defined disorder—Capecitabine—colon cancer	0.000512	0.000762	CcSEcCtD
Memantine—Urticaria—Fluorouracil—colon cancer	0.000512	0.000762	CcSEcCtD
Memantine—Conjunctivitis—Methotrexate—colon cancer	0.00051	0.000761	CcSEcCtD
Memantine—Anaemia—Capecitabine—colon cancer	0.00051	0.000759	CcSEcCtD
Memantine—Body temperature increased—Fluorouracil—colon cancer	0.000509	0.000759	CcSEcCtD
Memantine—Hypersensitivity—Vincristine—colon cancer	0.000509	0.000758	CcSEcCtD
Memantine—Haematuria—Methotrexate—colon cancer	0.000501	0.000746	CcSEcCtD
Memantine—Malaise—Capecitabine—colon cancer	0.000497	0.000741	CcSEcCtD
Memantine—Hepatobiliary disease—Methotrexate—colon cancer	0.000497	0.00074	CcSEcCtD
Memantine—Epistaxis—Methotrexate—colon cancer	0.000495	0.000738	CcSEcCtD
Memantine—Vertigo—Capecitabine—colon cancer	0.000495	0.000738	CcSEcCtD
Memantine—Hypersensitivity—Irinotecan—colon cancer	0.000495	0.000738	CcSEcCtD
Memantine—Asthenia—Vincristine—colon cancer	0.000495	0.000738	CcSEcCtD
Memantine—Syncope—Capecitabine—colon cancer	0.000494	0.000737	CcSEcCtD
Memantine—Leukopenia—Capecitabine—colon cancer	0.000494	0.000735	CcSEcCtD
Memantine—Agranulocytosis—Methotrexate—colon cancer	0.00049	0.00073	CcSEcCtD
Memantine—Palpitations—Capecitabine—colon cancer	0.000487	0.000726	CcSEcCtD
Memantine—Loss of consciousness—Capecitabine—colon cancer	0.000485	0.000722	CcSEcCtD
Memantine—Asthenia—Irinotecan—colon cancer	0.000482	0.000719	CcSEcCtD
Memantine—Cough—Capecitabine—colon cancer	0.000481	0.000717	CcSEcCtD
Memantine—Hypertension—Capecitabine—colon cancer	0.000476	0.000709	CcSEcCtD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—colon cancer	0.000475	0.0106	CbGpPWpGaD
Memantine—Hypersensitivity—Fluorouracil—colon cancer	0.000474	0.000707	CcSEcCtD
Memantine—Haemoglobin—Methotrexate—colon cancer	0.000474	0.000706	CcSEcCtD
Memantine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000473	0.0106	CbGpPWpGaD
Memantine—Diarrhoea—Vincristine—colon cancer	0.000472	0.000704	CcSEcCtD
Memantine—Hepatitis—Methotrexate—colon cancer	0.000471	0.000703	CcSEcCtD
Memantine—Haemorrhage—Methotrexate—colon cancer	0.000471	0.000703	CcSEcCtD
Memantine—Myalgia—Capecitabine—colon cancer	0.000469	0.0007	CcSEcCtD
Memantine—Arthralgia—Capecitabine—colon cancer	0.000469	0.0007	CcSEcCtD
Memantine—Chest pain—Capecitabine—colon cancer	0.000469	0.0007	CcSEcCtD
Memantine—Pharyngitis—Methotrexate—colon cancer	0.000468	0.000697	CcSEcCtD
Memantine—Anxiety—Capecitabine—colon cancer	0.000468	0.000697	CcSEcCtD
Memantine—Urinary tract disorder—Methotrexate—colon cancer	0.000466	0.000694	CcSEcCtD
Memantine—Discomfort—Capecitabine—colon cancer	0.000464	0.000691	CcSEcCtD
Memantine—Urethral disorder—Methotrexate—colon cancer	0.000462	0.000689	CcSEcCtD
Memantine—Diarrhoea—Irinotecan—colon cancer	0.00046	0.000686	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—CHST5—colon cancer	0.00046	0.0103	CbGpPWpGaD
Memantine—Dry mouth—Capecitabine—colon cancer	0.000459	0.000684	CcSEcCtD
Memantine—Dizziness—Vincristine—colon cancer	0.000456	0.00068	CcSEcCtD
Memantine—Pruritus—Fluorouracil—colon cancer	0.000456	0.000679	CcSEcCtD
Memantine—Visual impairment—Methotrexate—colon cancer	0.000454	0.000677	CcSEcCtD
Memantine—Confusional state—Capecitabine—colon cancer	0.000454	0.000676	CcSEcCtD
Memantine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000451	0.0101	CbGpPWpGaD
Memantine—Oedema—Capecitabine—colon cancer	0.00045	0.000671	CcSEcCtD
Memantine—GRIN2B—Reelin signaling pathway—PIK3CA—colon cancer	0.000449	0.0101	CbGpPWpGaD
Memantine—Infection—Capecitabine—colon cancer	0.000447	0.000666	CcSEcCtD
Memantine—GRIN1—EPHB-mediated forward signaling—SRC—colon cancer	0.000446	0.00999	CbGpPWpGaD
Memantine—Erythema multiforme—Methotrexate—colon cancer	0.000446	0.000664	CcSEcCtD
Memantine—Dizziness—Irinotecan—colon cancer	0.000445	0.000663	CcSEcCtD
Memantine—Shock—Capecitabine—colon cancer	0.000443	0.00066	CcSEcCtD
Memantine—Nervous system disorder—Capecitabine—colon cancer	0.000441	0.000658	CcSEcCtD
Memantine—Eye disorder—Methotrexate—colon cancer	0.000441	0.000657	CcSEcCtD
Memantine—Diarrhoea—Fluorouracil—colon cancer	0.000441	0.000657	CcSEcCtD
Memantine—Thrombocytopenia—Capecitabine—colon cancer	0.000441	0.000657	CcSEcCtD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	0.00044	0.00986	CbGpPWpGaD
Memantine—Tinnitus—Methotrexate—colon cancer	0.00044	0.000655	CcSEcCtD
Memantine—Tachycardia—Capecitabine—colon cancer	0.000439	0.000654	CcSEcCtD
Memantine—Vomiting—Vincristine—colon cancer	0.000439	0.000654	CcSEcCtD
Memantine—Cardiac disorder—Methotrexate—colon cancer	0.000438	0.000652	CcSEcCtD
Memantine—Skin disorder—Capecitabine—colon cancer	0.000437	0.000651	CcSEcCtD
Memantine—Rash—Vincristine—colon cancer	0.000435	0.000649	CcSEcCtD
Memantine—Hyperhidrosis—Capecitabine—colon cancer	0.000435	0.000648	CcSEcCtD
Memantine—GRIN2B—EPHB-mediated forward signaling—SRC—colon cancer	0.000435	0.00974	CbGpPWpGaD
Memantine—Dermatitis—Vincristine—colon cancer	0.000435	0.000648	CcSEcCtD
Memantine—Headache—Vincristine—colon cancer	0.000432	0.000645	CcSEcCtD
Memantine—GRIN2A—Reelin signaling pathway—AKT1—colon cancer	0.000431	0.00966	CbGpPWpGaD
Memantine—Anorexia—Capecitabine—colon cancer	0.000429	0.000639	CcSEcCtD
Memantine—Angiopathy—Methotrexate—colon cancer	0.000428	0.000637	CcSEcCtD
Memantine—Vomiting—Irinotecan—colon cancer	0.000427	0.000637	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—colon cancer	0.000426	0.000635	CcSEcCtD
Memantine—Dizziness—Fluorouracil—colon cancer	0.000426	0.000635	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—colon cancer	0.000425	0.000633	CcSEcCtD
Memantine—Rash—Irinotecan—colon cancer	0.000424	0.000632	CcSEcCtD
Memantine—Dermatitis—Irinotecan—colon cancer	0.000424	0.000631	CcSEcCtD
Memantine—Chills—Methotrexate—colon cancer	0.000423	0.00063	CcSEcCtD
Memantine—Headache—Irinotecan—colon cancer	0.000421	0.000628	CcSEcCtD
Memantine—Hypotension—Capecitabine—colon cancer	0.00042	0.000627	CcSEcCtD
Memantine—Alopecia—Methotrexate—colon cancer	0.000417	0.000621	CcSEcCtD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—colon cancer	0.000414	0.00927	CbGpPWpGaD
Memantine—Mental disorder—Methotrexate—colon cancer	0.000413	0.000616	CcSEcCtD
Memantine—Malnutrition—Methotrexate—colon cancer	0.00041	0.000612	CcSEcCtD
Memantine—Nausea—Vincristine—colon cancer	0.00041	0.000611	CcSEcCtD
Memantine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00041	0.000611	CcSEcCtD
Memantine—Vomiting—Fluorouracil—colon cancer	0.000409	0.00061	CcSEcCtD
Memantine—Insomnia—Capecitabine—colon cancer	0.000407	0.000607	CcSEcCtD
Memantine—Rash—Fluorouracil—colon cancer	0.000406	0.000605	CcSEcCtD
Memantine—Dermatitis—Fluorouracil—colon cancer	0.000406	0.000604	CcSEcCtD
Memantine—Paraesthesia—Capecitabine—colon cancer	0.000404	0.000602	CcSEcCtD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—colon cancer	0.000404	0.00904	CbGpPWpGaD
Memantine—Headache—Fluorouracil—colon cancer	0.000403	0.000601	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—colon cancer	0.000402	0.000599	CcSEcCtD
Memantine—Dyspnoea—Capecitabine—colon cancer	0.000401	0.000598	CcSEcCtD
Memantine—Nausea—Irinotecan—colon cancer	0.000399	0.000595	CcSEcCtD
Memantine—Back pain—Methotrexate—colon cancer	0.000397	0.000592	CcSEcCtD
Memantine—Dyspepsia—Capecitabine—colon cancer	0.000396	0.00059	CcSEcCtD
Memantine—Decreased appetite—Capecitabine—colon cancer	0.000391	0.000583	CcSEcCtD
Memantine—GRIN2A—Post NMDA receptor activation events—HRAS—colon cancer	0.000391	0.00875	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000388	0.000579	CcSEcCtD
Memantine—Fatigue—Capecitabine—colon cancer	0.000388	0.000578	CcSEcCtD
Memantine—Vision blurred—Methotrexate—colon cancer	0.000387	0.000576	CcSEcCtD
Memantine—Pain—Capecitabine—colon cancer	0.000385	0.000573	CcSEcCtD
Memantine—Constipation—Capecitabine—colon cancer	0.000385	0.000573	CcSEcCtD
Memantine—Nausea—Fluorouracil—colon cancer	0.000382	0.00057	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—colon cancer	0.000381	0.000568	CcSEcCtD
Memantine—Anaemia—Methotrexate—colon cancer	0.000379	0.000565	CcSEcCtD
Memantine—GRIN2B—ErbB4 signaling events—PIK3CA—colon cancer	0.000375	0.00841	CbGpPWpGaD
Memantine—Feeling abnormal—Capecitabine—colon cancer	0.000371	0.000553	CcSEcCtD
Memantine—Malaise—Methotrexate—colon cancer	0.00037	0.000552	CcSEcCtD
Memantine—Vertigo—Methotrexate—colon cancer	0.000369	0.00055	CcSEcCtD
Memantine—Gastrointestinal pain—Capecitabine—colon cancer	0.000368	0.000548	CcSEcCtD
Memantine—Leukopenia—Methotrexate—colon cancer	0.000367	0.000548	CcSEcCtD
Memantine—GRIN1—Axon guidance—DCC—colon cancer	0.000367	0.00822	CbGpPWpGaD
Memantine—GRIN2B—Reelin signaling pathway—AKT1—colon cancer	0.000367	0.00821	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TOP1—colon cancer	0.000362	0.0081	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—colon cancer	0.00036	0.00806	CbGpPWpGaD
Memantine—Cough—Methotrexate—colon cancer	0.000358	0.000534	CcSEcCtD
Memantine—GRIN2B—Axon guidance—DCC—colon cancer	0.000358	0.00801	CbGpPWpGaD
Memantine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000358	0.00801	CbGpPWpGaD
Memantine—Urticaria—Capecitabine—colon cancer	0.000357	0.000533	CcSEcCtD
Memantine—Abdominal pain—Capecitabine—colon cancer	0.000356	0.00053	CcSEcCtD
Memantine—Body temperature increased—Capecitabine—colon cancer	0.000356	0.00053	CcSEcCtD
Memantine—Convulsion—Methotrexate—colon cancer	0.000356	0.00053	CcSEcCtD
Memantine—Chest pain—Methotrexate—colon cancer	0.000349	0.000521	CcSEcCtD
Memantine—Arthralgia—Methotrexate—colon cancer	0.000349	0.000521	CcSEcCtD
Memantine—Myalgia—Methotrexate—colon cancer	0.000349	0.000521	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	0.000348	0.00778	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—CASP3—colon cancer	0.000347	0.00778	CbGpPWpGaD
Memantine—Discomfort—Methotrexate—colon cancer	0.000345	0.000515	CcSEcCtD
Memantine—GRIN1—Post NMDA receptor activation events—HRAS—colon cancer	0.000341	0.00763	CbGpPWpGaD
Memantine—Confusional state—Methotrexate—colon cancer	0.000338	0.000503	CcSEcCtD
Memantine—Infection—Methotrexate—colon cancer	0.000333	0.000496	CcSEcCtD
Memantine—GRIN2B—Post NMDA receptor activation events—HRAS—colon cancer	0.000332	0.00744	CbGpPWpGaD
Memantine—Hypersensitivity—Capecitabine—colon cancer	0.000332	0.000494	CcSEcCtD
Memantine—Nervous system disorder—Methotrexate—colon cancer	0.000328	0.00049	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—colon cancer	0.000328	0.000489	CcSEcCtD
Memantine—Skin disorder—Methotrexate—colon cancer	0.000325	0.000485	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—colon cancer	0.000324	0.000483	CcSEcCtD
Memantine—Asthenia—Capecitabine—colon cancer	0.000323	0.000481	CcSEcCtD
Memantine—Anorexia—Methotrexate—colon cancer	0.000319	0.000476	CcSEcCtD
Memantine—Pruritus—Capecitabine—colon cancer	0.000318	0.000474	CcSEcCtD
Memantine—GRIN1—EPHB-mediated forward signaling—HRAS—colon cancer	0.000314	0.00703	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—colon cancer	0.000314	0.00703	CbGpPWpGaD
Memantine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000314	0.00702	CbGpPWpGaD
Memantine—Hypotension—Methotrexate—colon cancer	0.000313	0.000466	CcSEcCtD
Memantine—Diarrhoea—Capecitabine—colon cancer	0.000308	0.000459	CcSEcCtD
Memantine—GRIN2B—EPHB-mediated forward signaling—HRAS—colon cancer	0.000306	0.00685	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—colon cancer	0.000306	0.00685	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000305	0.000455	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—CASP3—colon cancer	0.000303	0.00678	CbGpPWpGaD
Memantine—Insomnia—Methotrexate—colon cancer	0.000303	0.000452	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—colon cancer	0.000301	0.000448	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—colon cancer	0.000299	0.000445	CcSEcCtD
Memantine—Somnolence—Methotrexate—colon cancer	0.000298	0.000444	CcSEcCtD
Memantine—Dizziness—Capecitabine—colon cancer	0.000298	0.000443	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—CASP3—colon cancer	0.000295	0.00661	CbGpPWpGaD
Memantine—Dyspepsia—Methotrexate—colon cancer	0.000295	0.000439	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.000293	0.00656	CbGpPWpGaD
Memantine—Decreased appetite—Methotrexate—colon cancer	0.000291	0.000434	CcSEcCtD
Memantine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000289	0.000431	CcSEcCtD
Memantine—Fatigue—Methotrexate—colon cancer	0.000289	0.00043	CcSEcCtD
Memantine—Pain—Methotrexate—colon cancer	0.000286	0.000427	CcSEcCtD
Memantine—Vomiting—Capecitabine—colon cancer	0.000286	0.000426	CcSEcCtD
Memantine—Rash—Capecitabine—colon cancer	0.000284	0.000423	CcSEcCtD
Memantine—Dermatitis—Capecitabine—colon cancer	0.000283	0.000422	CcSEcCtD
Memantine—Headache—Capecitabine—colon cancer	0.000282	0.00042	CcSEcCtD
Memantine—Feeling abnormal—Methotrexate—colon cancer	0.000276	0.000411	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—colon cancer	0.000274	0.000408	CcSEcCtD
Memantine—Nausea—Capecitabine—colon cancer	0.000267	0.000398	CcSEcCtD
Memantine—Urticaria—Methotrexate—colon cancer	0.000266	0.000397	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—APC—colon cancer	0.000266	0.00596	CbGpPWpGaD
Memantine—Abdominal pain—Methotrexate—colon cancer	0.000265	0.000395	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—colon cancer	0.000265	0.000395	CcSEcCtD
Memantine—GRIN1—Developmental Biology—DCC—colon cancer	0.000262	0.00587	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—APC—colon cancer	0.000259	0.00581	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.000256	0.00573	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—DCC—colon cancer	0.000255	0.00572	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.000249	0.00558	CbGpPWpGaD
Memantine—Hypersensitivity—Methotrexate—colon cancer	0.000247	0.000368	CcSEcCtD
Memantine—Asthenia—Methotrexate—colon cancer	0.00024	0.000358	CcSEcCtD
Memantine—Pruritus—Methotrexate—colon cancer	0.000237	0.000353	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—PTGS2—colon cancer	0.000237	0.0053	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—SRC—colon cancer	0.00023	0.00514	CbGpPWpGaD
Memantine—Diarrhoea—Methotrexate—colon cancer	0.000229	0.000342	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—SRC—colon cancer	0.000224	0.00501	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—VEGFA—colon cancer	0.000224	0.00501	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—colon cancer	0.000223	0.00499	CbGpPWpGaD
Memantine—Dizziness—Methotrexate—colon cancer	0.000222	0.00033	CcSEcCtD
Memantine—GRIN1—Developmental Biology—HNF4A—colon cancer	0.00022	0.00494	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—BRAF—colon cancer	0.00022	0.00493	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CASP3—colon cancer	0.00022	0.00492	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—VEGFA—colon cancer	0.000218	0.00488	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HNF4A—colon cancer	0.000215	0.00481	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CCND1—colon cancer	0.000214	0.00479	CbGpPWpGaD
Memantine—Vomiting—Methotrexate—colon cancer	0.000213	0.000317	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000211	0.00473	CbGpPWpGaD
Memantine—Rash—Methotrexate—colon cancer	0.000211	0.000315	CcSEcCtD
Memantine—Dermatitis—Methotrexate—colon cancer	0.000211	0.000314	CcSEcCtD
Memantine—Headache—Methotrexate—colon cancer	0.00021	0.000313	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000204	0.00456	CbGpPWpGaD
Memantine—Nausea—Methotrexate—colon cancer	0.000199	0.000297	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—TP53—colon cancer	0.000194	0.00435	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—BRAF—colon cancer	0.000192	0.0043	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TP53—colon cancer	0.000189	0.00424	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—EP300—colon cancer	0.000189	0.00424	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—CASP3—colon cancer	0.000187	0.0042	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—BRAF—colon cancer	0.000187	0.0042	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—colon cancer	0.000186	0.00417	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—CASP3—colon cancer	0.000183	0.00409	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—CTNNB1—colon cancer	0.000181	0.00405	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000179	0.00401	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CA7—colon cancer	0.000178	0.00398	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—CTNNB1—colon cancer	0.000176	0.00394	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000176	0.00394	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—MYC—colon cancer	0.000172	0.00384	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TGFB1—colon cancer	0.000171	0.00383	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000169	0.00379	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—BRAF—colon cancer	0.000169	0.00378	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—EGFR—colon cancer	0.000168	0.00376	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—SRC—colon cancer	0.000163	0.00366	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CA7—colon cancer	0.000163	0.00365	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—HRAS—colon cancer	0.000162	0.00362	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—SRC—colon cancer	0.000159	0.00356	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—HRAS—colon cancer	0.000158	0.00353	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—EP300—colon cancer	0.000158	0.00353	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000149	0.00334	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—BRAF—colon cancer	0.000147	0.0033	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—BRAF—colon cancer	0.000144	0.00321	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—colon cancer	0.000141	0.00316	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ABCB1—colon cancer	0.00014	0.00314	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	0.000137	0.00307	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000135	0.00302	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CA7—colon cancer	0.000132	0.00295	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TYMS—colon cancer	0.000127	0.00285	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000118	0.00263	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—HRAS—colon cancer	0.000115	0.00257	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000115	0.00257	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—HRAS—colon cancer	0.000112	0.00251	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CHST5—colon cancer	0.000108	0.00241	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ODC1—colon cancer	0.000108	0.00241	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—AKT1—colon cancer	0.000101	0.00227	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—HRAS—colon cancer	0.000101	0.00227	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	9.99e-05	0.00224	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA7—colon cancer	9.95e-05	0.00223	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—AKT1—colon cancer	9.89e-05	0.00222	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CHST5—colon cancer	9.88e-05	0.00221	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ODC1—colon cancer	9.88e-05	0.00221	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—PPARG—colon cancer	9.57e-05	0.00214	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—PPARG—colon cancer	9.33e-05	0.00209	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PPARG—colon cancer	9.02e-05	0.00202	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—colon cancer	8.84e-05	0.00198	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—colon cancer	8.61e-05	0.00193	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—SRC—colon cancer	8.54e-05	0.00191	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DLC1—colon cancer	8.45e-05	0.00189	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—SRC—colon cancer	8.32e-05	0.00186	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—colon cancer	8.31e-05	0.00186	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—NRAS—colon cancer	8.21e-05	0.00184	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—colon cancer	8.1e-05	0.00181	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—NRAS—colon cancer	8e-05	0.00179	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ODC1—colon cancer	7.97e-05	0.00179	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CHST5—colon cancer	7.97e-05	0.00179	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LGR5—colon cancer	7.95e-05	0.00178	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—HRAS—colon cancer	7.76e-05	0.00174	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—BRAF—colon cancer	7.66e-05	0.00171	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—colon cancer	7.48e-05	0.00168	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—colon cancer	7.29e-05	0.00163	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—colon cancer	7.07e-05	0.00158	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TGFB1—colon cancer	6.89e-05	0.00154	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—colon cancer	6.89e-05	0.00154	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—colon cancer	6.77e-05	0.00152	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CTNNB1—colon cancer	6.74e-05	0.00151	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—colon cancer	6.6e-05	0.00148	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CTNNB1—colon cancer	6.57e-05	0.00147	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EP300—colon cancer	6.26e-05	0.0014	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EP300—colon cancer	6.11e-05	0.00137	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—SRC—colon cancer	6.09e-05	0.00136	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	6.07e-05	0.00136	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CHST5—colon cancer	6.03e-05	0.00135	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ODC1—colon cancer	6.03e-05	0.00135	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—colon cancer	6.01e-05	0.00135	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—SRC—colon cancer	5.94e-05	0.00133	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—colon cancer	5.93e-05	0.00133	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—EP300—colon cancer	5.9e-05	0.00132	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NRAS—colon cancer	5.86e-05	0.00131	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—colon cancer	5.86e-05	0.00131	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—colon cancer	5.78e-05	0.00129	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NRAS—colon cancer	5.71e-05	0.00128	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AXIN2—colon cancer	5.71e-05	0.00128	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TGFB1—colon cancer	5.44e-05	0.00122	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—colon cancer	5.34e-05	0.0012	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TGFB1—colon cancer	5.31e-05	0.00119	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—colon cancer	5.2e-05	0.00117	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—colon cancer	5.04e-05	0.00113	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—colon cancer	4.92e-05	0.0011	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	4.59e-05	0.00103	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—colon cancer	4.29e-05	0.00096	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—colon cancer	4.22e-05	0.000946	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—colon cancer	4.18e-05	0.000936	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—colon cancer	3.78e-05	0.000848	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—colon cancer	3.69e-05	0.000826	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—colon cancer	3.52e-05	0.000788	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—colon cancer	2.85e-05	0.000637	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMS—colon cancer	2.79e-05	0.000626	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—colon cancer	2.61e-05	0.000585	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMS—colon cancer	2.57e-05	0.000574	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.49e-05	0.000557	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—colon cancer	2.11e-05	0.000472	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMS—colon cancer	2.07e-05	0.000463	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—colon cancer	1.98e-05	0.000443	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.96e-05	0.000438	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—colon cancer	1.82e-05	0.000407	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGFR3—colon cancer	1.65e-05	0.000369	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.63e-05	0.000364	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—colon cancer	1.59e-05	0.000357	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMS—colon cancer	1.56e-05	0.00035	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—colon cancer	1.56e-05	0.000349	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APC—colon cancer	1.51e-05	0.000339	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—colon cancer	1.51e-05	0.000339	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—colon cancer	1.47e-05	0.000328	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—colon cancer	1.43e-05	0.00032	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BRAF—colon cancer	1.42e-05	0.000319	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—colon cancer	1.38e-05	0.000309	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—colon cancer	1.32e-05	0.000295	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—colon cancer	1.3e-05	0.000292	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—EP300—colon cancer	1.3e-05	0.00029	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.2e-05	0.00027	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—colon cancer	1.2e-05	0.000268	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—EP300—colon cancer	1.19e-05	0.000266	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—colon cancer	1.15e-05	0.000258	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—colon cancer	1.11e-05	0.000248	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—colon cancer	1.11e-05	0.000248	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—colon cancer	1.08e-05	0.000241	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—colon cancer	1.07e-05	0.000239	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—colon cancer	1.04e-05	0.000233	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—colon cancer	1.03e-05	0.00023	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1A—colon cancer	1e-05	0.000225	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—colon cancer	9.78e-06	0.000219	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—EP300—colon cancer	9.59e-06	0.000215	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—colon cancer	9.58e-06	0.000215	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EP300—colon cancer	9.56e-06	0.000214	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SRC—colon cancer	9.29e-06	0.000208	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—colon cancer	9.05e-06	0.000203	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—colon cancer	8.94e-06	0.0002	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—colon cancer	8.79e-06	0.000197	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—colon cancer	8.72e-06	0.000195	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—colon cancer	8.33e-06	0.000186	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—colon cancer	8.31e-06	0.000186	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—colon cancer	8.15e-06	0.000182	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—colon cancer	7.83e-06	0.000175	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—colon cancer	7.7e-06	0.000172	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—EP300—colon cancer	7.25e-06	0.000162	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—colon cancer	7.18e-06	0.000161	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—colon cancer	7.1e-06	0.000159	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—colon cancer	7.07e-06	0.000158	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—colon cancer	6.84e-06	0.000153	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—colon cancer	6.54e-06	0.000146	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—colon cancer	5.8e-06	0.00013	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—colon cancer	5.78e-06	0.000129	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—colon cancer	5.36e-06	0.00012	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—colon cancer	4.38e-06	9.81e-05	CbGpPWpGaD
